Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:16 PM
Ignite Modification Date:
2025-12-24 @ 1:16 PM
NCT ID:
NCT00286195
Eligibility Criteria:
Inclusion Criteria:
* Other lesions in different epicardial vessels must be successfully treated prior to bifurcation procedure.
* Native parent vessel suitable to receive at least a 2.5mm x 18mm FRONTIER stent (\>2.5mm and \<4.0mm diameter with a side branch of \>2.0mm) with a lesion length \<15mm determined by visual assessment .
* Target main branch vessel must be a major epicardial native vessel.
* Appropriate lesion morphology.
* Target lesion is restenosis following original treatment by PTCA only (no in-stent restenosis).
Exclusion Criteria:
* Estimated artery reference diameter \<2.5mm
* Patients with diffuse disease defined as long segments of abnormal vessel without interposed areas of normal vessel
* Target lesion contains thrombus.
* Target lesion is aorto-ostial or left main stem location.
* Untreated lesion \>50% diameter stenosis proximal or distal to target lesion after the planned target lesion intervention.
* Patients with a contraindication for anti-platelet / anti-coagulation therapy.
* Target lesion distal to previously placed stents.
* Fibrotic or calcified lesions that cannot be pre-dilated.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00286195
Study Brief:
Protocol Section:
NCT00286195